Get started
Author

Léa Hampe

First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial
2023 · Marion Thibaudin, Jean-David Fumet, et al. · Nature Medicine · 112
PDF
Follicular helper-T cells restore CD8+-dependent antitumor immunity and anti-PD-L1/PD-1 efficacy
2021 · Julie Niogret, Hélène Berger, et al. · Journal for ImmunoTherapy of Cancer · 111
PDF
Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer
2022 · Marion Thibaudin, Emeric Limagne, et al. · Cancer Immunology Immunotherapy · 69
PDF
Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer
2025 · Jean-David Fumet, Charlène Latour, et al. · Cancer Research · 20
Immunological features of coronavirus disease 2019 in patients with cancer
2020 · Marion Thibaudin, Jean-David Fumet, et al. · European Journal of Cancer · 17
PDF
Effect of radiochemotherapy on peripheral immune response in glioblastoma
2024 · Léa Hampe, Susy Daumoine, et al. · Cancer Immunology Immunotherapy · 7
Safety and efficacy of trifluridine/tipiracil +/− bevacizumab plus XB2001 (anti-IL-1α antibody): a single-center phase 1 trial
2025 · Marion Thibaudin, Nicolas Roussot, et al. · Signal Transduction and Targeted Therapy · 6
PDF
Immunohistochemistry Resolves Indeterminate MTAP Deletion Calls From Exome Sequencing: A Pan-Cancer Concordance Study
2026 · Marion Thibaudin, Julie Lecuelle, et al. · Modern Pathology
Supplementary Figure 2 from Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer
2026 · Jean-David Fumet, Charlène Latour, et al.
Supplementary Figure 4 from Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer
2026 · Jean-David Fumet, Charlène Latour, et al.
Supplementary Figure 3 from Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer
2026 · Jean-David Fumet, Charlène Latour, et al.
Supplementary Table 2 from Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer
2026 · Jean-David Fumet, Charlène Latour, et al.
Data from Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer
2026 · Jean-David Fumet, Charlène Latour, et al.
Supplementary Figure 8 from Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer
2026 · Jean-David Fumet, Charlène Latour, et al.
Supplementary Table 1 from Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer
2026 · Jean-David Fumet, Charlène Latour, et al.
Supplementary Figure 7 from Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer
2026 · Jean-David Fumet, Charlène Latour, et al.
Supplementary Figure 5 from Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer
2026 · Jean-David Fumet, Charlène Latour, et al.
Supplementary Figure 1 from Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer
2026 · Jean-David Fumet, Charlène Latour, et al.
Supplementary Figure 6 from Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer
2026 · Jean-David Fumet, Charlène Latour, et al.
Supplementary Table 3 from Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer
2026 · Jean-David Fumet, Charlène Latour, et al.
Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, KEAP1/STK11 co-mutated metastatic NSCLC
2024 · Nicolas Roussot, Marion Thibaudin, et al. · Frontiers in Immunology
Abstract CT217: First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b-2 trial
2024 · Marion Thibaudin, Jean-David Fumet, et al. · Cancer Research
Protocol for simultaneous analysis of peripheral and intratumoral lymphocyte function by flow cytometry
2023 · Susy Daumoine, Léa Hampe, et al. · STAR Protocols
Works count: 23
Citation count: 342
H-index: 6
I10-index: 5
Year
Topic
Type